NuWays Raises Nynomic Price Target to EUR 30 From EUR 28

By Public Technologies
  • NuWays raised Nynomic's 12-month target to EUR 30 from EUR 28 on Nov. 6, 2026, retaining its Buy rating.
  • Third-quarter sales rose 21.5% year over year to EUR 27.7 million, marking a third consecutive quarter of accelerating growth.
  • Quarterly EBIT reached EUR 3.1 million, representing an 11.2% margin versus NuWays' 8.3% estimate.
  • Order backlog increased 59% year over year to EUR 77.3 million, its highest level since the second quarter of 2023.
  • NuWays sees the upper end of fiscal 2026 guidance within reach: EUR 100–105 million sales, with a 6–8% EBIT margin.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nynomic AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_27348) on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.